Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hoogland Spine Products is a private German medical device company focused on endoscopic and minimally invasive spine surgery systems. Founded in 2006 by orthopedic surgeon Dr. Thomas Hoogland, the company develops, manufactures, and distributes instrumentation used in transforaminal, interlaminar, biportal, and fusion-related spinal procedures. Its flagship maxmorespine product family includes endoscopic systems and access instruments designed for treatment of herniated discs, disc degeneration, stenosis, and facet joint pathology. The company also emphasizes physician training, surgeon education, and global distribution support, and markets its products internationally through a network of distribution partners. It is not a drug-development biotech company; it is a commercial-stage spine medtech business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hoogland Spine Products.